Zacks Investment Management’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-10,322
Closed -$984K 574
2019
Q1
$984K Sell
10,322
-4,954
-32% -$618K 0.02% 399
2018
Q4
$1.9M Sell
15,276
-852
-5% -$140K 0.05% 240
2018
Q3
$3.94M Sell
16,128
-905
-5% -$209K 0.08% 181
2018
Q2
$3.17M Buy
17,033
+261
+2% +$43.4K 0.07% 197
2018
Q1
$2.06M Sell
16,772
-4,702
-22% -$574K 0.05% 257
2017
Q4
$2.56M Buy
21,474
+517
+2% +$56.9K 0.06% 217
2017
Q3
$1.99M Buy
20,957
+1,216
+6% +$117K 0.05% 249
2017
Q2
$1.88M Buy
19,741
+5,295
+37% +$453K 0.05% 247
2017
Q1
$1.12M Buy
+14,446
New +$1M 0.03% 329

Other funds holding INGN

Zacks Investment Management's INGN Position: Q2 2019 in Review

Zacks Investment Management sold out of Inogen (INGN) in Q2 2019, closing a stake of 10,322 shares — an estimated $984K sold.

Zacks Investment Management first reported a position in INGN in Q1 2017 and held it in 9 quarters. The position peaked at $3.94M in Q3 2018. 197 funds tracked by Wall St. Rank hold INGN as of Q2 2019.

  • Zacks Investment Management reported no remaining Inogen position as of Q2 2019 after selling out during the quarter.
  • Zacks Investment Management sold 10,322 Inogen shares in Q2 2019, an estimated $984K.
  • Zacks Investment Management first reported a position in Inogen in Q1 2017 and held it in 9 quarters.
  • Zacks Investment Management's Inogen position peaked at $3.94M in Q3 2018.
  • 197 funds tracked by Wall St. Rank held Inogen as of Q2 2019.

Based on Zacks Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.